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Abstract
Vector-borne diseases transmitted by insect vectors such as mosquitoes occur in over 100 countries and affect
almost half of the world’s population. Dengue is currently the most prevalent arboviral disease but chikungunya,
Zika and yellow fever show increasing prevalence and severity. Vector control, mainly by the use of insecticides,
play a key role in disease prevention but the use of the same chemicals for more than 40 years, together with the
dissemination of mosquitoes by trade and environmental changes, resulted in the global spread of insecticide
resistance. In this context, innovative tools and strategies for vector control, including the management of resistance,
are urgently needed. This report summarizes the main outputs of the first international workshop on Insecticide
resistance in vectors of arboviruses held in Rio de Janeiro, Brazil, 5–8 December 2016. The primary aims of this
workshop were to identify strategies for the development and implementation of standardized insecticide resistance
management, also to allow comparisons across nations and across time, and to define research priorities for control of
vectors of arboviruses. The workshop brought together 163 participants from 28 nationalities and was accessible, live,
through the web (> 70,000 web-accesses over 3 days).
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Background
Insecticide Resistance is recognized by the World Health
Organization (WHO) as an important threat to vector-
borne diseases control and prevention. There is an urgent
need to identify the countries and regions where resist-
ance could challenge vector control and to accelerate the
deployment of innovative tools for vector control. Better
understanding of the strength and dynamics of insecticide
resistance will help to develop a global strategy for insecti-
cide resistance containment in arboviruses vectors.
In March 2016, TDR, the Special Program for Research
and Training in Tropical Diseases in collaboration with
the WHO Neglected Tropical Diseases Department
(NTD/WHO), has supported the launch of the first-ever
international network to track insecticide resistance in
mosquito vectors of arboviruses. The Worldwide
Insecticide-resistance Network (WIN) https://win-network.
ird.fr/), aims to enhance the monitoring of insecticide
resistance worldwide, filling knowledge gaps and guiding
decision making for improved insecticide resistance man-
agement strategies and vector control [1].
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In December 5-8th 2016, the first International Work-
shop on “Insecticide resistance in vectors of emerging
arboviruses: Challenge and prospects for vector con-
trol” was held in Rio de Janeiro, Brazil, and was orga-
nized jointly by the Brazilian Instituto Oswaldo Cruz
(IOC) and the French Institut de Recherche pour le
Développement (IRD) and Centre National de la
Recherche Scientifique (CNRS). Representatives from 94
institutions working on vector-borne diseases were
present including research institutions and universities,
international organizations (WHO, CDC), development
agencies (e.g. USAID), ministries of health and members
of the private sector. The workshop brought together
163 participants from 28 nationalities and was access-
ible, live, through the web (> 70,000 web-accesses over
the 3 days). The workshop served as a forum to identify
priorities in vector research and to provide national au-
thorities with recommendations for the improvement of
insecticide resistance management and deployment of
alternative vector control tools.
During the workshop, three scientific plenary sessions
were organized: the first session dedicated to the “Emer-
gence of arboviruses diseases” addressed the causes
and consequences of the expansion of arboviral diseases
and their vectors and discussed challenges for improving
their control. The second session dedicated to “Insecti-
cide resistance” focused on the current distribution,
mechanisms, fitness cost and impact of insecticide resist-
ance on vector control and discussed challenges in re-
sistance diagnostics and monitoring. The last plenary
session dedicated to “Innovative vector control” pre-
sented new developments in chemical, biological and
genetic approaches for controlling mosquito vectors and
reducing arboviruses transmission. Each plenary session
comprised multiple presentations by scientists followed
by open discussions with all participants. Scientific ses-
sions were followed by a plenary “Industry session”
where representatives of the agrochemical sector and vec-
tor control consortium presented innovative tools and
promoted private-public partnership for the development
of new public health insecticides. In addition, 30 posters
were presented by scientists and industry. Finally, two
discussion round tables open to all participants were orga-
nized to leverage the knowledge of the audience into strat-
egies that may accelerate the translation of vector
research into policies and programs. The meeting agenda,
list of speakers, registered participants and presentations
are available at https://win-network.ird.fr/.
Welcoming addresses
The first day was opened with welcoming addresses by
representatives of the Brazilian Ministry of Health, the
French Ministry of Foreign Affairs in Brazil, the Instituto
Oswaldo Cruz, the WHO NTD and TDR departments,
and the Pan American Health Organization (PAHO). All
speakers acknowledged the scale of the emergency
caused by arboviral diseases worldwide and called for
stronger commitment and international cooperation to
sustain vector control and combat insecticide resistance.
Dr. Ademir Martins (FIOCRUZ/IOC) welcomed partici-
pants and presented the objectives of the meeting. Dr.
Vincent Corbel (IRD, France) then introduced the
Worldwide Insecticide resistance Network (WIN) [1]
that brings together 19 internationally recognized insti-
tutions in vector research with the aim to monitor and
contain insecticide resistance worldwide. The WIN, which
is supported by the WHO-TDR program, was commis-
sioned to develop in-depth reviews of the current know-
ledge and gaps in insecticide resistance management and
effective vector control strategies (accessible online
through the WIN website). The ultimate goal of the WIN
is to develop an international consortium aiming at
strengthening the capacity of national authorities in in-
secticide resistance monitoring and management.
Session 1: Emergence of arbovirus diseases
Prof. Annelies Wilder-Smith (Lee Kong Chian School of
Medicine, Singapore) opened the first session by
summarizing the increasing problem caused by epidemic
arboviral diseases in the twenty-first century. The last
five decades have witnessed an unprecedented emer-
gence of epidemics of arboviral diseases including
dengue, chikungunya, yellow fever, and Zika transmitted
by Aedes mosquitoes. The recent epidemiological history
of what became the Zika emergency started with the
2007 outbreak in Micronesia, followed by Polynesia in
2013, and Brazil in 2014 from where it rapidly spread to
neighboring countries and the Caribbean. Recent out-
breaks of yellow fever (YF) began in Angola (884
confirmed cases) and neighboring countries (Mauritania,
Kenya, DRC) in December 2015 and the YF virus spread
to Asia for the first time in history (11 cases reported in
China). Chikungunya virus (CHIKV) caused havoc in
2013–2014 when a reemerging strain was introduced
into and swept through the Caribbean and Latin
America at an unprecedented speed and scale. How-
ever, the most important arboviral disease remains den-
gue due to its broad distribution, increased epidemic
activity, hyper-endemicity and disease severity. The fre-
quency and magnitude of dengue epidemics have in-
creased significantly over the past 40 years (Fig. 1).
Overcrowded urban settings facilitate transmission via
Aedes mosquitoes as documented recently in Singapore
[2]. Among the major causes of emergence of arboviral
diseases are demographic changes, massive urbanization,
population movement, trade, and lack of effective control,
all of which favor the worldwide spread of both the virus
and the vector.
Corbel et al. Parasites & Vectors  (2017) 10:278 Page 2 of 16
Dr. Pedro Vasconcelos (Instituto Evandro Chagas,
Brazil), described the causes and consequences of the
Zika virus outbreak in Brazil. First occurrences of an
exanthematic syndrome of Zika were reported in the
State of Rio Grande do Norte in October 2014 [3]. Re-
sults of phylogenetic and molecular clock-based ana-
lyses showed a single introduction of ZIKV into the
Americas possibly from French Polynesia [4]. The virus
has caused 1.5 million cases in Brazil and may have
been introduced during an international sporting event
[5]. First associations between Zika and microcephaly
were demonstrated in northeastern Brazil [6]. Subse-
quently 72 countries and territories have reported evi-
dence of mosquito-borne Zika virus transmission since
2007 (Fig. 2), among which 20 countries have reported
microcephaly and other usually-rare CNS malfor-
mations, especially Guillain-Barré syndrome, potentially
associated with Zika virus infection [7]. Multiple modes
of transmission of Zika virus are possible: vector,
sexual, perinatal, saliva, congenital, blood transfusion,
and possibly urine. Association with other malforma-
tions and other complications (deafness, ocular alter-
ations, arthrogryposis, cranio-facial size disproportion,
calcifications, etc.) is likely. Vaccines for Zika are at
early stage of development [8].
Dr. Raman Velayudhan (Neglected Tropical Diseases
Department, World Health Organization, Switzerland)
described the WHO response and preparedness for
arbovirus vector control. The presentation started by
reviewing early success stories of eradication campaigns
of arboviral diseases in South America using source re-
duction and effective targeted residual spraying with in-
secticides as part of centralized, vertically-structured
programs. According to the WHO, well-implemented
vector control programs using targeted residual spray-
ing, space spraying, larval control and personal pro-
tective measures can be effective in reducing the
transmission of Aedes-borne diseases including Zika.
Therefore, sustaining vector control must remain a pri-
ority. This includes accurate vector and clinical surveil-
lance, implementation of Integrated Vector Management
(IVM) and strengthening national capacity for better
preparedness for the emerging threat of arboviruses. The
Global Vector Control Response currently being devel-
oped by the WHO will aim to enhance vector control
capacity and foster research and innovation in this field.
Fig. 1 Global spread of dengue virus (Courtesy of Dr. A. Wilder-Smith). Copyright: Creative Commons Attribution 4.0 License (https://creativecom
mons.org/licenses/by/4.0/). Citation: Messina et al. (2014) Global spread of dengue virus types: mapping the 70 year history. Trends in Microbiology.
2014;22(3):138–146 [67]
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Prof. Dina Fonseca (Rutgers University, USA) gave a
talk on insecticide resistance and the globalization of
Aedes mosquitoes. Invasive mosquitoes such as Culex
pipiens, Cx. quinquefasciatus, Ae. aegypti and Ae.
albopictus have driven most of the recent arboviral epi-
demics. Invasive mosquitoes are widespread and abun-
dant because they exploit human environments. Aedes
aegypti, originally from Africa, Aedes albopictus as well
as more recently Aedes japonicus, originally from Asia,
have become established worldwide. Population genetic
studies have shown that Ae. aegypti spread across the
New World probably around 1500 CE, Ae. albopictus after
the 1960s and Ae. japonicus in the late 1990s [9, 10] but
successive (re-) introductions of these species appear as a
common pattern [11]. Anthropization and increases in the
worldwide circulation of goods also favor mosquito ex-
pansion by creating favorable conditions promoting the
dispersal of immature stages [12]. One of the primary
threats associated with mosquito expansions is the
introduction of insecticide resistant populations into new
territories, potentially undermining decades of IR manage-
ment. Understanding the factors that promote invasive-
ness will allow the development of better strategies for
prevention and control of invasive disease vectors.
Dr. Anne Wilson (Durham University, School of Bio-
sciences, UK) presented the concept of Integrated Vec-
tor Management (IVM) in the context of arbovirus
control. IVM is an evidence-based, adaptive and multi-
sectoral approach to vector control [13]. Briefly, it
involves a range of vector control tools used either alone
or in combination selected based on knowledge of the
local vector ecology and disease epidemiology. Dr.
Wilson provided examples of IVM strategies for Aedes-
control and pinpointed the benefits of IVM for insecti-
cide resistance management. In Mexico, improving
housing by using long lasting insecticide-treated house
screens and targeted larviciding resulted in long lasting
significant reductions in Ae. aegypti infestations [14].
Cluster randomized controlled trials in Nicaragua and
Mexico demonstrated that evidence-based community
mobilization is effective at reducing both vector popula-
tions and dengue infections in children [15]. The discus-
sion outlined some of the challenges in implementing
IVM at large scale such as establishing and sustaining
inter-sectoral collaboration, and highlighted opportun-
ities for advancing IVM for Aedes control.
Dr. Mylène Weill (Institute of Evolutionary Sciences,
University of Montpellier, France), described the
Fig. 2 Global spread of Zika virus 1947–2016 (in: WHO June 2016, http://www.who.int/emergencies/zika-virus/zika_timeline.pdf?ua=1)
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evolution of insecticide resistance in vectors of human
diseases. Resistance to insecticides has spread in most
mosquito vectors through selection. Different adaptive
mechanisms have proliferated depending on the selective
pressure and mosquito species. Non-synonymous muta-
tions in insecticide targets such as AChE1 (ace-1 muta-
tion), GABA (rdl mutation) and the para voltage-gated
sodium channel (kdr mutations) were compared in
terms of their impacts on the fitness of mosquito popu-
lations [16]. For example, the G119S mutation confer-
ring resistance to organophosphates and carbamates
strongly impacts development time, mating competition,
mortality, fecundity and predation in Anopheles gambiae
and Culex pipiens [17, 18], though gene duplication
serves to mitigate these fitness costs [19]. In Ae. aegypti,
individuals possessing kdr mutations exhibited slower
larval development and lower fecundity compared to
their susceptible counterparts [20]. These trade-offs con-
tribute to the persistence of insecticide resistance in the
field, its local dynamics and spread among geographical
areas. Understanding the relations between mutations, fit-
ness and selective pressure in mosquito vectors of human
diseases is needed to improve the management of resist-
ance and contribute to the success of vector control.
During the ensuing general discussion, members of the
audience raised concerns about the underestimated
burden of arboviral diseases in Africa. It was proposed
that screening for arbovirus serotypes in malaria negative
cases could help to improve the surveillance and preven-
tion of neglected arbovirus diseases in this part of the
world. The WHO-TDR representative confirmed that the
program will engage resources to improve the arbovirus
diagnostic capacity of national centres in West Africa to
prevent further outbreaks. The WHO-NTD representative
also indicated that specific guidelines for the implementa-
tion, monitoring and evaluation of arbovirus vector con-
trol are being developed for the African region.
Session 2: Insecticide resistance in arbovirus
vectors
This session started with talks describing the status of
insecticide resistance in arbovirus vectors in different re-
gions of the world.
Dr. Beniamino Caputo (Sapienza University of Rome,
Italy) presented data supporting the rise of pyrethroid
resistance in Ae. albopictus in Italy, particularly in the
northern regions where a chikungunya outbreak occurred
in 2007. Insecticide resistance is also widespread in Cx.
pipiens populations. In this area, the intense usage of
chemical insecticides for urban mosquito control has
likely exerted a strong selection pressure on Ae. albopictus
and Cx. pipiens. Resistance management strategies should
be further considered in Italy and more widely in Europe
to contain insecticide resistance in arbovirus vectors.
Dr. Mamadou Coulibaly (University of Sciences, Tech-
niques and Technologies, Bamako, Mali) reviewed the
insecticide resistance status of Ae. aegypti and Ae. albo-
pictus in Africa. Although these two vectors are present
in several African countries, there is a paucity of data on
insecticide resistance, probably due to the focus on mal-
aria vectors. Available data showed that resistance of Ae.
aegypti to DDT and pyrethroids is present in both cen-
tral and West-African countries and involves both knock
down (kdr) mutations and metabolic resistance mecha-
nisms [21–26]. Resistance to other insecticide classes
(organophosphates) has also been reported although
data are limited to a few countries. In the context of the
circulation of arboviral diseases in Africa, this presenta-
tion highlighted the need to improve the monitoring of
insecticide resistance in Aedes mosquitoes in Africa, es-
pecially in Eastern regions from which data are absent.
Dr. Hassan Vatandoost (Tehran University of Medical
Sciences, Iran) summarized the diversity of vector-borne
diseases affecting the Eastern Mediterranean Region and
their consequences for public health and then presented
an overview of the resistance status of local populations
of Ae. aegypti and Ae. albopictus. Data from this region
support the presence of insecticide resistance although
significant variations in resistance levels were recorded
probably linked to different vector control practices and
methods [27–29]. He concluded by emphasizing the
need for better coordination between insecticide resist-
ance monitoring and management at the regional level.
He also reported some resistant status of other arboviral
vectors such as Culex, Sandfly and ticks in the region.
Dr. Feng-Xia Meng (Chinese Center of Disease Con-
trol and Prevention, Beijing, China) started by describing
the data management system for insecticide resistance in
China. Vectors monitored include Cx. pipiens, Cx. quin-
quefasciatus, Ae. aegypti, Ae. albopictus and Cx. tritae-
niorhynchus. She showed the results of insecticide
resistance analyses indicating that Ae. aegypti and Ae.
albopictus have developed resistance to pyrethroids in
several provinces such as Guangdong and Yunnan
whereas resistance to organophosphates and carbamates
were moderate in most provinces. Both kdr mutations
and metabolic resistance mechanisms have been de-
tected in Aedes mosquitoes.
Dr. Kamaraju Rhagavendra (National Institute for Mal-
aria Research, Delhi, India) described the diversity of ar-
boviruses circulating in India and their consequences for
public health. The few insecticide resistance data avail-
able revealed widespread resistance to DDT in Ae.
aegypti across the country while resistance to organo-
phosphates appeared more frequent in southern India.
Pyrethroid resistance in Ae. aegypti and Ae. albopictus
was reported in Delhi and Kerala regions [30–33]. Chal-
lenges for the control of arboviral diseases in India
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include the development of vector surveillance and resist-
ance monitoring programs and the implementation of
rational vector control strategies throughout the country.
Dr. Haroldo Bezerra (Pan American Health Organization,
USA) presented the key challenges for strengthening vector
management in the Americas. These include: evaluating
the risk of arbovirus transmission, reducing mosquito
breeding sites density, implementing efficient entomological
surveillance and vector control, developing knowledge and
skills in entomology, evaluating vector control practices
and monitoring insecticide resistance. In the context of the
increasing insecticide resistance of arbovirus vectors in the
Americas, the PAHO promotes the implementation of inte-
grated vector control (IVM).
Dr. Constância Ayres (Fundação Oswaldo Cruz, Brazil)
presented an overview of the resistance status of Ae.
aegypti in South America. She proposed that the eradi-
cation campaign implemented from 1950 to 1970 might
have led to the selection and spread of DDT resistance.
Decades later, the occurrence of temephos resistance
due to the intensive use of organophosphates for larval
control [34] has led to the gradual replacement of these
insecticide families by Bti and insect growth regulators
[35, 36]. Similarly, the use of pyrethroids for space spray-
ing together with existing cross-resistance mechanisms
(especially kdr mutations) previously selected by DDT
led to the rapid rise of pyrethroid resistance. Overall,
this presentation underscored the widespread high levels
of insecticide resistance in South American Ae. aegypti
that may impact the efficacy of conventional insecticides
in the prevention of arbovirus transmission.
The following presentations were dedicated to the lat-
est advances related to: the global mapping of insecticide
resistance; the understanding of associated molecular
mechanisms; the development of novel diagnostic tools;
the evaluation of the impact of resistance on vector con-
trol; and the development of insecticide resistance man-
agement strategies.
First, Dr. Catherine Moyes (University of Oxford,
Oxford, UK) described the work performed by the WIN
community to update insecticide resistance databases and
generate worldwide resistance maps for Ae. aegypti and
Ae. albopictus. About 6700 bioassay data points were col-
lected from all continents and used for mapping the global
distribution of insecticide resistance between 2008 and
2016. Overall, this work confirmed the wide distribution of
insecticide resistance in Ae. aegypti to all insecticide fam-
ilies (Fig. 3). Although less information is available for Ae.
albopictus, resistance to various insecticides was reported
especially in Asia. Dr. Moyes presentation highlighted the
need for standardized protocols and novel diagnostic tools
for monitoring insecticide resistance worldwide.
Dr. Azael Che-Mendoza (National Center for Disease
Control and Prevention, Ministry of Health, Mexico)
Fig. 3 Global distribution of insecticide resistance data in Aedes mosquitoes
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described the main strategies that have been imple-
mented by the Ministry of Health of México in response
to insecticide resistance in the country. As observed in
many places, the use of DDT in the 1950–1960s
followed by the use of pyrethroids in the 1990s selected
for kdr-based pyrethroid resistance in Mexico [37] that
has significantly affected vector control efficacy. This in
turn has led to changes in insecticide policy for mos-
quito control. The development of a nation-wide web-
based surveillance systems integrating epidemiological,
entomological and resistance data [38] aims to preserve
the effectiveness of insecticides in the control of vector-
borne diseases in Mexico.
The following presentation by Dr. Shinji Kasai (Na-
tional Institute of Infectious Diseases, Japan) focused on
target-site mutations affecting the voltage-gated sodium
channel targeted by pyrethroids and DDT, several of
which confer kdr phenotypes (Fig. 4). Although multiple
kdr mutations have been described in Ae. aegypti, elec-
trophysiological studies suggest that only a few of them
(i.e. S989P, F1534C, V1016G) appear to result in pyreth-
roid resistance phenotypes directly or synergistically, and
that the combination of different mutations plays a key
role in determining resistance levels to different pyre-
throids [39]. The recent detection of mosquitoes carry-
ing all three of these mutations in South-East Asia
raised concerns for the management of pyrethroid resist-
ance. In Ae. albopictus, individuals carrying mutations at
the 1534 codon were recently detected in Singapore and
China hence suggesting that the increasing exposure of
the tiger mosquito to pyrethroids is selecting for resist-
ance [40, 41]. Research priorities include studying the
spatio-temporal dynamics of kdr mutations and validat-
ing their importance in the resistance phenotype to vari-
ous insecticides [42].
Dr. Jean-Philippe David (Centre National de la Recherche
Scientifique, Grenoble, France) gave a presentation about
the genetics of metabolic resistance in arbovirus vectors
(Fig. 4). After defining the evolutionary bases of metabolic
resistance, the current knowledge on the role of detoxifica-
tion enzymes in the resistance of Aedes mosquitoes to dif-
ferent insecticide families was reviewed and knowledge
gaps identified. A global analysis of detoxification enzymes
in multiple resistant populations from different continents
identified a set of robust genes underpinning metabolic re-
sistance in Ae. aegypti and Ae. albopictus. Recent genomic
analyses suggest that copy number variations (CNV) play a
key role in the over-production of detoxification enzymes
conferring resistance to insecticides in Aedes mosquitoes,
opening the way for the design of novel DNA-based diag-
nostic assays to track metabolic resistance in the field [43].
Future research efforts will aim to enlarge the panel of vali-
dated markers of metabolic resistance, evaluating their im-
portance in conferring resistance to various insecticides,
identifying their associated fitness costs and developing
novel diagnostic tools for monitoring their dynamics in
natural mosquito populations.
Dr. John Vontas (Foundation for Research and Tech-
nology - Hellas, Crete, Greece) presented the latest de-
velopments in diagnostic markers for tracking
insecticide resistance in arbovirus vectors. He discussed
the value of improving current resistance surveillance
tools to guide decision-making process for resistance
management. Dr. Vontas then reviewed resistance-
monitoring tools such as bioassays, biochemical assays
and molecular diagnostics tools both currently in use
and those under development. Overall, this presentation
highlighted the benefit of combining bioassays and mo-
lecular diagnostics for gathering contemporary and per-
tinent information for resistance management as well as
for implementing integrated vector control approaches.
This session ended with a presentation from Dr.
Isabelle Dusfour (Institut Pasteur de la Guyane,
Cayenne, French Guiana) about insecticide resistance
Fig. 4 Mechanisms of resistance to chemical insecticides in mosquitoes
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management strategies applicable to mosquito vectors of
arboviruses. She emphasized that selection of resistance
can be influenced by various factors including insect biol-
ogy, genetics of resistance and insecticide applications. Ex-
perience from the past indicates that Insecticide Resistance
Management (IRM) strategies must be integrated within
vector control programs at an early stage before resistance
occurs. IRM should include regular monitoring of resist-
ance together with careful implementation, monitoring and
evaluation of resistance-breaking interventions. Such inter-
ventions include rotations, mosaics or combinations of un-
related insecticides as well as source reduction. Developing
insecticide resistance management plans for Aedes mosqui-
toes will require improving resistance monitoring systems,
engaging populations to IRM, developing novel diagnostic
tools, evaluating operational insecticide resistance risk
levels, enlarging the panel of available insecticides, and pro-
moting the use of non-insecticidal control tools as part of
integrated vector control management.
Session 3: Innovative vector control approaches
for emerging arboviruses
This morning plenary session opened with an introduc-
tory talk given by Dr. John Vontas (IMBB/Forth, Crete,
Greece) in lieu of Dr. Nicole L. Achee (Eck Institute,
USA) who was unable to attend the meeting. The talk
contextualized the major obstacles that vector-borne dis-
ease control programs currently face in terms of the
relatively limited methodological options available for
vector control. Whilst current vector control methods
can reduce transmission if rigorously applied, to date
vector control has often been relatively ineffective in
preventing the spread of arboviral infections. Coupled
with the rise of insecticide resistance in Aedes popula-
tions and the limited arsenal of insecticides available for
public health, this justifies the urgent need for new vec-
tor control tools. Mosquito ecology is the common de-
nominator for the development of new vector control
products [44] and over 16 novel approaches are in the
pipeline targeting different phases of the mosquito’s life-
cycle and specific behaviors (Fig. 5). Attractive toxic
sugar baits, Wolbachia-based control, spatial repellents,
self-limiting genetic technologies (e.g. SIT and RIDL),
trapping methods, and new chemical insecticide-based
approaches, including new products and mode of actions
as well as auto-dissemination strategies were specifically
described. Although promising, evidence-based demon-
stration of the epidemiological impact of most of these
Fig. 5 Some examples of new vector control tools having a potential role in insecticide resistance management in dengue vectors (Courtesy of
Dr. N. Achee). Copyright: Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/). Citation: Achee et al. (2015) A
critical assessment of vector control for dengue prevention. PLoS Neglected Tropical Diseases 2015; 9(5):e0003655 [68]
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novel tools is missing and undermine calls for deploy-
ment at large scale.
Following the introductory note, the session had nine
presentations focused on more specific developments in
vector control. Three talks were specifically devoted to
advances in insecticide-based vector control.
Dr. Fabrice Chandre (IRD, France) gave an overview of
the potential use of mixtures and combinations of insec-
ticides with different modes of action in the island of
Martinique, where Ae. aegypti has developed resistance
to organophosphate and pyrethroid insecticides [45].
Pilot studies have provided promising results both at the
larval stage (spinosad + pyriproxyfen combination) and
at the adult stage (neocotinoids + pyrethroid combin-
ation) [46, 47].
The use of synergists to overcome insecticide resist-
ance was also the central topic of the presentation made
by Dr. Bruno Lapied (Univ. Angers, France) who pro-
vided an overview of the recent advances in the develop-
ment of alternative approaches using biological (insect
viruses) and chemical (repellents) synergistic agents
mixed with insecticides [48, 49].
Addressing personal protection needs, Mr. James
Orsborne (LSHTM, UK) presented an update on the ef-
forts to develop insecticide-treated clothing as a means
of personal protection against Aedes bites and arbovirus
transmission [50]. These studies involved both con-
trolled testing in laboratory conditions (free flight
rooms) and a school-based randomized trial imple-
mented in Thailand enrolling children from ten schools
with insecticide-treated school uniforms [51]. In the
trial, treated clothing appeared to have reduced the Ae-
des population inside school in the first month of the
study. However, due to poor insecticide retention within
the clothing, there was no significant difference in den-
gue prevalence between insecticide-treated and control
schools [52]. Novel treatment techniques and strategies
were also presented. With innovative treatment tech-
niques that bind deeper into fabrics increasing insecti-
cide retention as well as development of ‘wash-in
repellent detergents’ that could be rapidly distributed
during an arbovirus outbreak.
Dr. Rui-De Xue (Anastasia Mosquito Control District,
USA) gave a talk on new repellents for personal protection
against arbovirus vectors. After reviewing formulations
and efficacy data for commercially available repellents (e.g.
DEET, picaridin, IR-3535), focus was given to some of the
most promising new molecules that are currently being
tested such as the experimental repellent piperidine. Ovi-
position repellents are also gaining importance in the
treatment of container breeding sites.
Dr. Rui-De Xue also presented a talk on attractive
toxic sugar baits (ATSB) for controlling arboviruses on
behalf of Dr. Whitney Qualls (Texas Department of
State Health Services, USA). This approach takes advan-
tage of the sugar feeding behavior inherent to all adult
mosquitoes. ATSB uses sugar as a bait to expose male
and female mosquitoes to a deadly toxin (e.g. boric acid).
The approach is also being tested in combination with
pyriproxyfen and results point to effective control of
both adult and larval Ae. albopictus, highlighting the
versatility of ATSB for vector control [53].
Dr. Stephen L. Dobson (University of Kentucky, USA)
focused on autocidal methods for Aedes control. This
strategy involves the use of mosquitoes as “insecticides-
delivery” agents to reduce/suppress vector populations
[54]. The talk summarized the results of Auto-
Dissemination Augmented by Males (ADAM) strategy
carried out in the USA [55]. The trial was based on the
field-release of Ae. albopictus males contaminated with
pyriproxifen (PPF). The males either contaminated the
females during mating or directly contaminated larval
habitats (Fig. 6). Although the Ae. albopictus population
declined in one site following the introduction of PPF-
treated males, further data on male dispersion and sur-
vival as well as on the size and location of the release
are still needed to validate the efficacy of the ADAM
strategy for Aedes control.
Dr. Margareth Capurro (Universidade de São Paulo,
Brazil) gave a presentation on the recent developments
towards the improvement of transgenic Ae. aegypti
strains for the control of arbovirus transmission in
Brazil. An overview of the ongoing experimental trials in
Bahia, Brazil was given (e.g. PAT Project: open field re-
lease of OX513A Ae. aegypti transgenic line). The trial
conducted over a year showed that the local Ae. aegypti
population was reduced by 95% based on adult trap and
81% based on ovitrap indices compared to the adjacent
no-release control area [56]. Experience suggests that
genetic control tools may however be insufficient to
completely suppress vector populations. An alternative
would be to sequentially implement a suppression strat-
egy to significantly reduce the mosquito populations
followed by the implementation of a population replace-
ment strategy. Such an approach should be implemented
within the framework of integrated vector control.
Dr. Lee Ching Ng (National Environment Agency,
Singapore) described the implementation of the “Wolba-
chia Project” in Singapore, for the control of Ae. aegypti.
Following the recrudescence of dengue and emergence
of Zika in Singapore [2], the National Environment
Agency has studied the potential use of Wolbachia-in-
fected males for population suppression. This ambitious
project involved initial studies on the effectiveness of the
Wolbachia population strategy strains, risk assessment
analysis to ensure the safety of the technology and a
strong community engagement component. A field cali-
bration study was implemented to define the release
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strategy and the mosquito monitoring system (e.g. traps,
sentinel sites, data analysis). The talk provided an over-
view of the developments of the project at different
stages, highlighting the importance of community en-
gagement as a means to increase receptivity to the vec-
tor control strategy.
The session ended with an open discussion between
the speakers and the audience. The discussion
highlighted the promising results so far obtained in the
development of new vector control tools. However, more
evidence-based data are required to assess the effective-
ness and potential impact of novel tools especially if
there are intended for use as part of IVM. Emphasis was
made of the critical need for community engagement for
the effective implementation of new vector control strat-
egies. When suppression or replacement strategies have
to be considered, it is highly recommended to release
mosquitoes having “local genetic background” to avoid
operational control failure (e.g. this was observed at Rio
de Janeiro, Brazil during the first release of insecticide
susceptible Wolbachia-infected mosquitoes that did not
survive in presence of pyrethroids).
Session 4: Private-public partnership for the de-
velopment of new tools for arbovirus vector
control
The session aimed at discussing the challenge of insecti-
cide resistance in the context of developing new effective
tools for insect vector control from the insecticide man-
ufacturer’s perspective. Representatives of the agrochem-
ical sector (28 companies were represented), Innovative
vector Control Consortium (IVCC) and Insecticide
Resistance Action Committee (IRAC) attended the
workshop to present efficacy data and share their experi-
ence of vector control and resistance management.
Mr. John Lucas (Sumitomo Chemical Co., UK) pro-
vided an overview of the Insecticide Resistance Action
Committee (IRAC) that was formed in 1984 to provide a
coordinated industry approach to counter the develop-
ment of resistance in pests and mites (http://www.irac-
online.org/about/irac/). The challenge of insecticide
resistance in insects that impact public health comes
from the limited arsenal of new chemistries. This has
been exacerbated by a major decline in the number of
companies actively involved in insecticide development.
Presently agricultural pesticides are being repurposed for
vector control because vector control is a small market
(2% of a total pesticide market estimated at over $50 bil-
lion USD), representing low profit and poor investment
returns. Consequently the options for resistance man-
agement are few, and rely on appropriate resistance
monitoring, proactive IRM strategies (e.g. mixtures, mo-
saic and sequences of unrelated insecticides) and suscep-
tible genes preservation [57].
Mrs. Melinda Hadi (Vestergaard Frandsen, Switzerland)
addressed the need for dedicated tools for monitoring in-
secticide resistance in Aedes mosquitoes. Vestergaard
Frandsen has recently expanded IR mapper (www.irmap-
per.com), to include a mapping platform that provides
geospatial displays of insecticide resistance data in Ae.
aegypti and Ae. albopictus taken from peer-reviewed,
published literature. The platform includes information
on resistance to different classes of insecticides generated
by different methods (e.g. test tubes and bottle assays, lar-
val bioassays, biochemical and molecular tools). As of
November 2016, 71% of the countries and territories
Fig. 6 Diagram comparing the auto-dissemination station-based approach with the Auto-Dissemination Augmented by Males (ADAM) (Courtesy of
Dr. S. Dobson). Copyright: Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/). Modified from the original picture
by S. Dobson. Citation: Mains et al. (2015) Male mosquitoes as vehicles for insecticide. PLoS Neglected Tropical Diseases 2015, 9(1):e0003406 [55].
Corbel et al. Parasites & Vectors  (2017) 10:278 Page 10 of 16
reported confirmed resistance in Aedes spp. to at least one
of the four main insecticide classes.
Dr. Julian Entwistle (Innovative Vector Control Con-
sortium (IVCC), UK) provided a portfolio of new public
health insecticide products under development funded
by the IVCC. IVCC is a product development partner-
ship that invests donor funds in R&D to overcome the
financial barriers to product innovation in vector con-
trol, as described by John Lucas (http://www.ivcc.com/).
Products that have been successfully developed so far in-
clude two long lasting indoor residual spraying products
and two potentially-resistance breaking LLINs for mal-
aria control. Three new paradigms targeting outdoor
transmission are under consideration in Africa; attractive
toxic sugar baits (ATSB), the push-pull strategy (spatial
repellent with attractant baited traps) and swarm-
targeted space sprays. Although the primary focus of
IVCC has been on technology for the control of malaria
vectors, many of the products and strategies that are be-
ing developed may be adapted to arbovirus vectors.
Dr. Frédéric Schmitt (Bayer, France) presented data on
a new insecticide combination to control mosquitoes in
areas of established or emerging resistance to conven-
tional insecticides. The new formulated product for
space spray application (Bayer708) combines two active
ingredients with different modes of action i.e. a pyreth-
roid and a new AChR modulator belonging to the bute-
nolid classes. Semi-field trials in USA and Brazil showed
a very good efficacy of the combination against suscep-
tible and pyrethroid resistant mosquitoes (Aedes, Culex
and Anopheles) up to 100 m away from the spray source.
In India, the combination sprayed indoors outperformed
the local standard sprays (pyrethroid-based formula-
tions) against Cx. quinquefasciatus and showed full effi-
cacy against Ae. aegypti. The combination of two modes
of action offers interesting potential for insecticide re-
sistance management.
Mr. Kevin Riozzi (Yanco, UK) gave a talk on innova-
tive insecticide products, including innovative mosquito
coils and insecticide papers co-developed with Bayer
Cropscience (Germany). According to the manufacturer,
the insecticide paper containing 0.45% transfluthrin pro-
vides 100% fast kill (<10 min) against resistant mosqui-
toes indoors (An. gambiae, Cx. quinquefasciatus and Ae.
aegypti). Insecticide papers offer interesting prospects
for protecting vulnerable people against indoor and day-
time mosquito bites at low cost.
Dr. Andreas Rose (Biogents AG, Germany) discussed
the relevance of deploying combination of source reduc-
tion and traps for host-seeking females (BGS), or traps
for gravid females (CDC-AGO & BG-GAT) to sustain
vector control. Originally used in surveillance and moni-
toring, research has demonstrated the potential of BGS
traps as a vector control tool [58]. Studies with area-
wide use of AGO in Puerto Rico have shown an 80% re-
duction in the density of female Ae. aegypti up to 1 year
[59] and significant reduction in chikungunya exposure
[60]. In Brazil, a recent study showed significant reduc-
tion in abundance of gravid Ae. aegypti by BG-GAT
[61]. According to the manufacturer, those traps are ef-
fective, practical, affordable, and could be easily de-
ployed as part of IVM.
Mr. Yoshinori Shono (Sumitomo Chemical Co., Japan)
presented the result of a new long lasting matrix-release
formulation containing pyriproxyfen (SumiLarv®2MR) for
larval control. Pyriproxyfen is an insect growth regulator
with a low mammalian toxicity recommended by the
WHO for use in drinking water [62]. According to the
manufacturer, field simulated experiments showed that
SumiLarv®2MR provided good efficacy against Aedes
sp. up to 25 weeks after treatment. In Lao PDR,
SumiLarv®2MR applied every 6 months to domestic
water storage containers resulted in a significant
reduction in Ae. aegypti larval densities for 18 months.
The long-lasting efficacy of SumiLarv®2MR may allow
reduction of the number of treatments per year,
hence resulting in reduced operational costs.
Mr. Peter DeChant (ValentBioSciences, USA), pre-
sented resistance management in IVM programs based
on operational use of Bacillus thuringiensis israelensis
(AM65–52) for the control of dengue, chikungunya, and
Zika vectors. Despite more than 32 years of operational
use in mosquito control, no resistance has developed to
commercial formulations of Bti AM65–52. The synergis-
tic action of Cyt-1a with the 4 cry toxins offers a form of
intrinsic resistance management, which protects against
resistance development [63]. Direct application of Bti
AM65–52 WG in Cambodia and Wide Area Spray of Bti
AM65–52 WG in Malaysia reduced the incidence of hu-
man dengue from 43%–93%, respectively [64, 65]. The
potential of Bti for IRM was discussed.
Dr. William Jany (Clarke International LLC, USA) pre-
sented the potential of using spinosad as a candidate for
temephos resistance management in Brazil. Spinosad has
a unique mode of action compared to other products by
targeting nicotinic acetylcholine receptor (nAChR) sub-
units. Semi-field trials were conducted in 4 sites in Brazil
using Ae. aegypti populations having different types of
resistance. The final conclusion was that there was no
cross resistance between temephos and spinosad and ef-
ficacy tests showed high residual activity of spinosad DT
(mortality >80%) in treated tanks up to 8 weeks. The
conclusion was that Spinosad may be an alternative tool
for organophosphate resistance management.
Mr. Herbert Nyberg (New Mountain Innovations,
USA) on the development of Acoustic Larvicide™ for
Urban Mosquito Control. The principle is that specific
acoustic resonance can induce the rupture of the dorsal
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tracheal trunk of mosquito larvae, causing death. Accord-
ing to the manufacturer, the Acoustic Larvicide™ is envir-
onmentally friendly, fast acting and highly specific. New
Mountain Innovations has developed and in some cases
already commercialized a wide range of acoustic products
(ultra-portable, Remotely Operated Vehicle, etc.) to target
various sizes and types of mosquito breeding habitats (e.g.
small ponds, road ditch, sewer systems/natural, etc.). Mr.
Nyberg reported that studies are ongoing to demonstrate
the efficacy of Acoustic Larvicide™ to reduce mosquito
population densities at the community level.
Reports from round tables
Round table 1: New tools for arbovirus vector control
New approaches to vector control
With insecticide resistance to existing Public Health in-
secticides increasing, control of adult Aedes will soon
depend on a few insecticides with novel targets some
still in development. Meanwhile there has been an in-
crease in innovative strategies for the deployment of
existing insecticides such as toxic sugar baits, insecticide
treated paper, window curtains or eave access tubes,
auto-dissemination traps, mass deployment of lethal ovi-
traps, and combinations of repellents and attractants
(push-pull). New strategies for larval control are limited,
but nonetheless include promising acoustic larvicides
and entomopathogenic fungi. Furthermore, new ap-
proaches using the rickettsia symbiont, Wolbachia, or
genetic modifications have revolutionized the sterile
male technique (Wolbachia SIT and RIDL SIT), can also
reduce larval production by interference competition
(fsRIDL SIT) and create pathogen refractory adults
(wMel in Ae. aegypti). However, while these approaches
are available and some already in use, they often require
extensive and expensive multiple releases. This limita-
tion can be addressed by the use of gene drive mecha-
nisms that while promising are, however, still elusive and
controversial.
Capacity building and new approaches to evaluation
Beyond new control approaches, there is a clear need for
better equipment availability, standardization and cali-
bration, trained personnel and funds to sustain high
quality operations (i.e. capacity building). Fundamentally,
however, there is a need to streamline registration of
new products and for better epidemiological evidence to
be incorporated into assessment standards. This may re-
quire the development of new strategies such as bio-
markers of human vector exposure (e.g. antibodies or
vector DNA) as part of the evaluation process paving
the way for faster evaluation of effects on transmission
risk, the ultimate metric of control effectiveness.
Development of new partnerships
Whilst recent suboptimal control by aerial spraying in
Miami in response to the Zika threat implicate insecti-
cide resistance (http://efish.fiu.edu/publications/Stod-
dard_Mosquito_spray_analysis_v3.pdf ), in the USA and
Europe the threat of resistance is perhaps less well
acknowledged than in the tropics. This may be partly be-
cause in developed countries professionals not associ-
ated with research institutions often perform vector
control and IR studies do not reach the peer-reviewed
literature. Moving forward there is a clear need for bet-
ter communication among researchers and Mosquito/
Pest Control professionals to monitor, evaluate and
minimize the development of insecticide resistance.
Likewise there is a critical need to inform and collabor-
ate with Public Health officials that excel in public out-
reach and, importantly, often control funding streams.
The following priorities were identified:
 Promote more bridges between Industry and
Academia both to speed-up product development but
also for a better evaluation of the relative effectiveness
of different strategies for Aedes control and the
development of protocols for post-application
assessment (QA/QC) and epidemiological effects, as
well as environmental side-effects.
 Development of an expert committee to evaluate
prospective biocides and to define conditions for
pilot deployment, especially in the context of
combination interventions (IVM) to streamline
registration of new products.
 Work on guidelines for good laboratory practice
(GLP) and good experimental practice (GEP) with
certified sites to speed up product evaluation and
registration. Concomitantly, the development of a
worldwide expert database would help in this way.
 Work on response plans adapted to countries need
and capacities for arboviral diseases outbreaks,
through optimized guidelines and making use of
local resources (e.g. for countries with existing
capacity for malaria control to co-opt resources,
expertise and equipment for the control of vectors
of arboviruses).
 Strengthen capacity of national authorities for vector
control and particularly for testing and evaluation of
insecticide products and new tools.
Round table 2: Improving insecticide resistance
surveillance and management
Diagnosis and interpretation of resistance
There is still a lack of accessible data sets documenting
levels of insecticide resistance in countries affected by
mosquito-transmitted arboviruses (especially in Africa
and Australasia), and when the data are available, there
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is considerable variation in the methodologies used to
record these data making cross-comparisons between
sites very difficult. A lack of diagnostic doses for mul-
tiple insecticides was highlighted as a key problem,
which, along with a lack of WHO impregnated paper
supply for recommended concentrations, has under-
mined standardisation of resistance testing in Aedes.
Other major obstacles relate to the interpretation of
data, from an uncertainty in how to compare results
from WHO tube bioassays and CDC bottle bioassays, to
a more fundamental question of what results actually
mean operationally (i.e. when should bioassay results
lead to a change in vector control policy?).
Better facilities and capacity are required in most
countries to implement programs for bioassay-based IR
testing, with current resources often limiting activities to
just one or two laboratories per country. Given current
capacity limitations, and the need for some in depth
dose–response data, a restricted sentinel site structure
might represent a compromise, since spatial and tem-
poral population heterogeneity in mosquito populations
represents a challenge, and fine scale data will be re-
quired to calibrate predictive resistance maps.
Molecular diagnostics are currently underused for pre-
dictive purposes, and with DNA-based tests applicable
to almost any samples, marker-based assays present
great potential to yield fine-scaled data. Although pyr-
ethroid and DDT target-site mutations are well known
and can be detected by simple molecular diagnostic as-
says, genotype-phenotype association studies are needed
to address the independent and combined effects of
those mutations (for example, at least 10 mutations are
associated with resistance phenotypes in Ae. aegypti but
only a few have definitely been shown to lead to resist-
ance). Functional validation of DNA markers for most
metabolic resistance mechanisms is also a priority to
speed up the implementation of resistance management
strategies and help choosing alternative insecticide based
on cross-resistance patterns associated with circulating
resistance alleles.
Surveillance systems and cross-sectoral interactions
There are substantial gaps in surveillance systems for
arboviral vectors, most notably in Africa facing increas-
ing arbovirus outbreaks, and there is a general need for
better cooperation among vector-borne disease control
programmes targeting different diseases (such as arbovi-
ruses vs malaria), decision-making entities and funding
agencies. A major problem has always been the poor
organization and integration of resistance datasets gen-
erated by research institutions, as well as the interpret-
ation and utilization of these data by relevant decision
making entities. The effectiveness of cross-sectoral inter-
actions also varies between countries; a problem that
WHO through the Global Vector Control response
(GVCR) will attempt to address via the establishment of
national task force to make evidence-based recommen-
dations on vector control, including how key interactors
should work together (http://www.who.int/malaria/
areas/vector_control/Draft-WHO-GVCR-2017-
2030.pdf?ua=1&ua=1).
Insecticide resistance management (IRM)
This proved to be an area of considerable uncertainty, in
part arising from difficulties underlying the interpret-
ation of resistance bioassay data, but also in whether or
how to integrate upcoming methods such as modified
insect releases, which are immensely promising but for
which costs, scalability and sustainability are unclear.
Nevertheless, it is recognised that alternative or comple-
mentary control methods that do not rely on traditional
neurotoxic insecticides, especially those with no recog-
nized resistance in the wild (e.g. Bti or spinosad) have a
major role to play. Fitness costs associated with insecti-
cide resistance are also a crucial parameter in resistance
management plans and require further exploration for
both target-site and metabolic resistance.
A key consideration highlighted was the need for strong
quality control at all levels of implementation, monitoring
and evaluation of IRM programmes, without which suc-
cess (or failure) cannot be judged. Helping low- and
middle-income countries to strengthen their capacity to
monitor insecticide resistance is a prerequisite to the im-
plementation of IRM at global scale. The lack of global
IRM plan for dengue and other arboviral diseases limits
national capacities to support availability and accessibility
of appropriate new vector control products.
The following priorities were identified:
 Establish insecticide resistance diagnostic doses for
each vector species of arboviruses and faster supply
delivery for insecticide testing to facilitate wider
screening programmes.
 Determine the genotype-phenotype association and
the predictive field value for target-site resistance
markers (e.g. kdr mutations) to know which
mutations are relevant for monitoring studies.
 Validation of metabolic-resistant markers and assays
for metabolic mechanisms require further
development.
 Encourage cross-sectoral interactions for improving
insecticide resistance monitoring and management.
Some examples of integration success stories (e.g.
Sudan) and also particularly effective surveillance
programmes (e.g. Mexico, Singapore) could serve as
training examples for good practice.
 Consider the implementation of ‘resistance-free’
interventions wherever possible as alternatives to
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application of traditional neurotoxic pesticides.
Develop evidence based guidelines to inform
countries on how and when such interventions
should be deployed at operational scale.
 When chemicals are in use for vector control,
rotations, mixtures and/or sequences of molecules
having different mode of action should be
encouraged providing robust monitoring and
evaluation of their resistance breaking potential.
 Development of a WHO GPIRM-style document for
resistance management in vectors of arboviruses
could be very valuable to give guidance on
interpretation of data and recommended resultant
actions.
Conclusion: Toward the development of an
international consortium for insecticide resistance
surveillance and management in arboviruses
vectors
Effective vector control has contributed to reducing ar-
boviruses transmission worldwide and is an essential
component of the WHO strategy for the prevention,
control, and elimination of Neglected Tropical Diseases
[66]. However, the last decades have seen emergence
and expansion of insecticide resistance in vectors,
coupled with a lack of appropriate response and pre-
paredness for resistance management. The WIN work-
shop in Brazil highlighted the need for more bridges and
partnerships between academia, research institutions,
international organizations, stakeholders, the civil soci-
ety and the private sector to manage insecticide resist-
ance and sustain vector control in endemic areas and
countries facing vector-borne diseases outbreaks.
In its first year of existence, the Worldwide Insecticide
resistance Network (WIN) has demonstrated its poten-
tial for collating and interpreting data and enlisting
cross-sectoral expertise in research and implementation
on the control of vectors of arboviruses. The next step
will be the development of an international consortium
to lead research and training activities on insecticide re-
sistance in vectors of emerging arboviruses and guide
policies for vector control.
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